SCHEMBL6979408

SCHEMBL6979408

CCCC(NC(=O)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
EP300 Q09472 5/20 0.41
GRM7 Q14831 2/20 0.41
FPR1 P21462 2/20 0.41
FPR2 P25090 2/20 0.41
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
AVPR2 P30518 2/20 0.40
OXTR P30559 2/20 0.40
AVPR1A P37288 2/20 0.40
HAT1 O14929 3/20 0.39
IDO1 P14902 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984354 0.89 PTGER4 (0.49) TP53EP300GRM7HDAC1HDAC8
SCHEMBL6977738 0.83 TP53 (0.51) TP53HDAC1HDAC8HDAC6IDO1
SCHEMBL7964635 0.82 TP53 (0.47) TP53EP300GRM7HDAC1HDAC8
SCHEMBL6984356 0.81 SMN1; SMN2 (0.53) TP53EP300HDAC1HDAC8HDAC6
SCHEMBL6977395 0.80 TP53 (0.46) TP53HDAC1HDAC8HDAC6AVPR2
SCHEMBL6978698 0.79 POLB (0.49) TP53HDAC1HDAC8HDAC6
SCHEMBL6979412 0.79 NAMPT (0.49) TP53HDAC1HDAC8HDAC6
SCHEMBL7085009 0.79 TP53 (0.49) TP53EP300FPR1FPR2HDAC1
SCHEMBL6985246 0.78 TP53 (0.51) TP53HDAC1HDAC8HDAC6IDO1
SCHEMBL7958428 0.78 MEN1 (0.46) TP53HDAC1HDAC8HDAC6AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed